menu search

PEP / Here's How Celsius Stock Rose 22% in November

Here's How Celsius Stock Rose 22% in November
A high-profile sports sponsorship agreement moved Celsius' needle a bit, but the first earnings report with results from a revamped distribution system did most of the heavy lifting. Read More
Posted: Dec 7 2022, 08:14
Author Name: The Motley Fool
Views: 111655

PEP News  

Coke and Pepsi stocks are both struggling — but one beverage giant has more to worry about than the other

By CNBC
October 28, 2023

Coke and Pepsi stocks are both struggling — but one beverage giant has more to worry about than the other

The beverage leaders' stocks have struggled this year as investors worry about higher interest rates and the possible negative impact of weight loss d more_horizontal

Top Consumer Staples Aristocrats to Buy Amid Recent Market Volatility

By Zacks Investment Research
October 27, 2023

Top Consumer Staples Aristocrats to Buy Amid Recent Market Volatility

The consumer staples sector has heavy representation on the dividends aristocrats list with several of these companies also being top-rated Zacks stoc more_horizontal

PepsiCo: Strong Growth Driven By Pricing And GLP-1 Anti-Obesity Drug Is Non-Structural

By Seeking Alpha
October 18, 2023

PepsiCo: Strong Growth Driven By Pricing And GLP-1 Anti-Obesity Drug Is Non-Structural

PepsiCo has experienced strong net pricing growth over the past decade, driven by portfolio premiumization and innovative product offerings. Concerns more_horizontal

What's Next For PepsiCo Stock After A Q3 Beat?

By Forbes
October 17, 2023

What's Next For PepsiCo Stock After A Q3 Beat?

PepsiCo (NYSE: PEP) recently reported its Q3 results, with revenues and earnings beating our estimates. more_horizontal

Are Ozempic and Similar Treatments Impacting Food and Beverage Stocks? Here's What Pepsi's CFO Said About It

By The Motley Fool
October 14, 2023

Are Ozempic and Similar Treatments Impacting Food and Beverage Stocks? Here's What Pepsi's CFO Said About It

Pepsi's CFO addressed the impacts of Ozempic and its sister treatments on the overall business. These comments come on the heels of a recent short rep more_horizontal

Pepsi's balanced approach to growth has analysts bullish

By Proactive Investors
October 11, 2023

Pepsi's balanced approach to growth has analysts bullish

Analysts at Barclays have modestly increased their price target for PepsiCo (NASDAQ:PEP) following the beverage giant's third quarter financial result more_horizontal

Cramer's Stop Trading: PepsiCo

By CNBC Television
October 11, 2023

Cramer's Stop Trading: PepsiCo

CNBC's Jim Cramer explains why he is keeping an eye on shares of PepsiCo. more_horizontal

PepsiCo Earnings Call: Stock Climbs As Drinks Company Reports Solid Earnings Beat

By Forbes
October 11, 2023

PepsiCo Earnings Call: Stock Climbs As Drinks Company Reports Solid Earnings Beat

As always, the devil is in the detail with these earnings reports - and while PepsiCo saw revenue increase, there was a drop in volume at the same tim more_horizontal


Search within

Pages Search Results: